Option care health and amedisys to combine creating a leading, independent platform for home and alternate site care

All-stock transaction combines highly complementary businesses unlocking significant benefits for patients, providers, payers, and care teams increases access to high quality care for communities across the u.s. through a unique national clinical platform comprehensive capabilities across alternate site care spectrum position combined company to move deeper into value-based care highly attractive combined financial profile which generated $6.2 billion in revenues and $622 million in adjusted ebitda on a combined basis for full year 2022 creates stockholder value including through anticipated annual run-rate revenue and cost synergies of approximately $75 million by year three following close companies to host joint conference call and webcast at 5:30 p.m. et today, may 3, 2023, to discuss transaction bannockburn, ill.
AMED Ratings Summary
AMED Quant Ranking